Drug interactions between dimercaprol and Escavite
|Escavite (multivitamin with iron and fluoride)|
Interactions between your drugs
dimercaprol multivitamin with iron and fluoride
Applies to: dimercaprol and Escavite (multivitamin with iron and fluoride)
Dimercaprol can bind with certain metals such as iron and selenium, forming a complex that is toxic to the kidneys. Products containing iron or selenium should not be used during dimercaprol therapy. If you are currently receiving or have recently received multivitamin with iron and fluoride, let your doctor know before receiving treatment with dimercaprol. You may need to wait at least 24 hours after the last dose of dimercaprol before you can start or resume multivitamin with iron and fluoride. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
multivitamin with iron and fluoride food
Applies to: Escavite (multivitamin with iron and fluoride)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.